News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Nicole Chmielewski-Stivers

Articles by Nicole Chmielewski-Stivers

33 MammaPrint® and BluePrint® Predict Anthracycline Chemosensitivity in Patients With HR+HER2– Early-Stage Breast Cancer Enrolled in FLEX

33 MammaPrint® and BluePrint® Predict Anthracycline Chemosensitivity in Patients With HR+HER2– Early-Stage Breast Cancer Enrolled in FLEX

ByWilliam Audeh, MD,Nicole Chmielewski-Stivers,Harshini Ramaswamy,Andrea Menicucci

June 30th 2024

Latest Updated Articles

Trending on CancerNetwork

FDA Grants Traditional Approval to Encorafenib in BRAF-Mutated CRC

FDA Grants Fast Track Designation to ART6043/Olaparib in BRCA-Mutated, HER2– Breast Cancer

Pembrolizumab Combo Yields Activity in Recurrent Gyn Clear Cell Carcinoma

Phase 2 Trial Begins Dosing of Cemsidomide Combo in R/R Multiple Myeloma

Nivolumab/Chemo Yields Long-Term Survival in Advanced Gastric Cancers